Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serotonin Stimulation and Pro-social Behavior
NCT06081179Phase 1Completed
- Sponsor
- University of Zurich
- Start
- Oct 2023
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of psilocybin and midomafetamine (3 arms), sponsored by University of Zurich. Primary endpoints: Multifaceted Empathy Test, Moral Inference Task and 8 more. Started Oct 2023; status: completed.
02
Drugs
psilocybinmidomafetamine
Beyond the preview
Go deeper on NCT06081179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06081179.